Two-Stage Revascularization in Patients with Acute Myocardial Infarction and Massive Coronary Thrombosis

Aim: to investigate safety and angiographic efficacy of two-stage revascularization with percutaneous coronary intervention (PCI) with stenting delayed by one day in patients with acute myocardial infarction (MI) and massive coronary thrombosis.

Materials and methods. We included in this study 12 patients with massive infarct related coronary artery thrombus which length was greater than thrice the vessel diameter in the presence of TIMI grade II–III blood flow as detected by coronary angiography (CAG). The emergency PCI was not performed, and conservative antithrombotic therapy continued for 24 hours. After this day, CAG was repeated.

Results. Repeat CAG in all patients showed thrombus regression which visually appeared as complete lysis in 8, and partial lysis – in 4 patients. Stenting of residual stenosis was performed in 11 patients without complications. In 1 patient residual stenosis was considered insignificant (<50 %) therefore stenting was not performed. No-reflowphenomenon and recurrent MI were not observed.

Conclusion. These data suggest that in patients with massive coronary artery thrombosis conservative antithrombotic therapy for 24 hours followed by repeated CAG and, if required, by stenting of residual stenosis, is safe treatment tactics that might reduce the risk of the no-reflow phenomenon.

1. Ibanez B., James S., Agewall S. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018; № 2 (39): 119–177. https://doi.org/10.1093/eurheartj/ehx393

2. Abbo K.M., Dooris M., Glasier S. et al. Features and outcome of no-reflow after percutaneous coronary intervention. AJC 1995;75(12):778–782.

3. Niccoli G., Burzotta F., Galiuto L. et al. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281–292.

4. Ndrepepa G., Tiroch K., Fusaro M. et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am College Cardiology 2010;55(21):2383–2389.

5. Movsesyants M.Y., Mironkov A.B., Abugov S.A. Primary percutaneous coronary intervention combined with prophylaxis of microcirculatory embolism: results of hospital and longterm observation. Cardiology and cardiovascular surgery 2012;4(5):13–17. Russian (Мовсесянц М.Ю., Миронков А.Б., Абугов С.А. Первичное чрескожное коронарное вмешательство в сочетании с профилактикой эмболии микроциркуля-торного русла: результаты госпитального и отдаленного периодов наблюдения. Кардиология и сердечно-сосудистая хирургия 2012;4(5):13–17).

6. Ahn S.G., Choi H.H., Lee J.H. et al. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Coron Artery Dis 2015;26(3):245–253. DOI: 10.1097/MCA.0000000000000197.

7. Niccoli G., Kharbanda R.K., Crea F., Banning A.P. No-reflow: again prevention is better than treatment. Eur Heart J 2010;31:2449–2455.

8. Jaffe R., Charron T., Puley G. et al. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008;117:3152–3156. doi.org/10.1161/CIRCULATIONAHA.107.742312.

9. Berg R., Buhari C. Treating and preventing no reflow in the cardiac catheterization laboratory. Curr Cardiol Rev 2012;8(3):209–214.

10. Sianos G., Papafaklis M.I., Serruys P.W. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 2010;22:6B–14B.

11. Ke D., Zhong W., Fan L., Chen L. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden. Coron Artery Dis 2012;23(7):497–506.

12. Semitko S. P., Analeev A. I., Gubenko I. M. et al. Results of sequential pharmacoinvasive treatment of ST elevation myocardial infarction with massive coronary thrombosis. Internatioal Journal of Interventional Cardioangiology 2013;35:70. Russian (Семитко С. П., Аналеев А. И. Губенко И. М. и др. Результаты поэтапного фармакоинвазивного лечения больных STEMI с массивным коронарным тромбозом. Международный журнал интервенционной кардиоангиологии 2013;35:70.)

13. Azarov A. V., Semitko S. P., Glezer М. G. et al. The results of delayed endovascular intervention in ST elevation acute myocardial infarction due to thrombotic occlusion of coronary artery. Cardiovascular therapy and prevention 2017; 16(1): 40–45. Russian (Азаров А. В., Семитко С. П., Глезер М. Г. и др. Результаты отсроченного эндо-васкулярного вмешательства у больных острым инфарктом миокарда с подъемом сегмента ST, обусловленным массив-ным тромбозом инфаркт-ответственной коронарной артерии. Кардиоваскулярная терапия и профилактика 2017; 16(1): 40–45).

14. Thygesen K., Alpert J. S., Jaffe A. S. et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551–2567. DOI: 10.1093/eurheartj/ehs184.

15. Kelbæk H., Høfsten D.E., Køber L., et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet 2016;387:2199–206. 10.1016/S0140-6736(16)30072-1

16. Freixa X., Belle L., Joseph L. et al. Immediate vs. delayed stenting in acute myocardial infarction: a systematic review and metaanalysis. EuroIntervention 2013; 8(10):1207–16. DOI: 10.4244/EIJV8I10A185.

17. Borgia F., Goodman S.G., Halvorsen S. et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 2010;31(17):2156–2169.

18. D’Souza S.P., Mamas M.A., Fraser D.G., Fath-Ordoubadi F. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST elevation myocardial infarction: a meta-analysis. Eur Heart J 2011;32(8):972–982.